Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVI-LM001 in Primary Hypercholesterolemia
CTR20191331Phase 2Completed
- Sponsor
- Sovay Pharmaceutical Technology
- Start
- Mar 2020
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of LM-001 in hypercholesterolemia, sponsored by Sovay Pharmaceutical Technology. Started Mar 2020; status: completed.
02
Drugs
LM-001
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on CTR20191331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191331.